Ignite Creation Date:
2025-12-24 @ 9:22 PM
Ignite Modification Date:
2026-04-10 @ 5:15 AM
Study NCT ID:
NCT00025532
Status:
WITHDRAWN
Last Update Posted:
2012-09-14
First Post:
2001-10-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Gastrointestinal Cancer
Sponsor:
University of California, San Francisco
Organization:
Conditions & Keywords Data
Conditions:
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | stage III colon cancer | View |
| None | stage IV colon cancer | View |
| None | stage III gastric cancer | View |
| None | stage IV gastric cancer | View |
| None | recurrent gastric cancer | View |
| None | stage III pancreatic cancer | View |
| None | recurrent pancreatic cancer | View |
| None | stage III rectal cancer | View |
| None | stage IV rectal cancer | View |
| None | recurrent colon cancer | View |
| None | recurrent rectal cancer | View |
| None | stage III esophageal cancer | View |
| None | stage IV esophageal cancer | View |
| None | recurrent esophageal cancer | View |
| None | adenocarcinoma of the stomach | View |
| None | adenocarcinoma of the esophagus | View |
| None | adenocarcinoma of the colon | View |
| None | adenocarcinoma of the rectum | View |
| None | adenocarcinoma of the pancreas | View |
| None | stage IV pancreatic cancer | View |